Walgreens Boots Alliance Inc (WBA)

Healthcare | Medical Pharmaceuticals
Latest reporting period: 2025-02-28

Latest Quarter

2025-02-28

Revenue

$38.6B

Net Income

-$2.9B

Operating Margin

-5.1%

Free Cash Flow

-$363M

Debt / Assets

85.0%

Values are in USD and rounded to the nearest whole number unless noted.

Swipe horizontally to view all columns.

Income statement quarterly history for Walgreens Boots Alliance Inc (WBA).
Income Statement (Quarterly) 2025-02-28 2024-11-30 2024-08-31 2024-05-31
Revenue 38,588,000,000 39,459,000,000 37,547,000,000 36,351,000,000
Cost of Revenue 31,654,000,000 32,680,000,000 31,294,000,000 29,892,000,000
Gross Profit 6,934,000,000 6,779,000,000 6,253,000,000 6,459,000,000
Operating Expenses
R&D Expenses 0 0 0 0
SG&A Expenses 8,891,000,000 7,015,000,000 6,948,000,000 6,393,000,000
Operating Expenses 12,501,000,000 7,024,000,000 7,230,000,000 6,348,000,000
Operating Income -1,956,000,000 -236,000,000 -977,000,000 111,000,000
Interest Expense 129,000,000 122,000,000 131,000,000 113,000,000
Income Before Tax -4,246,000,000 -415,000,000 -998,000,000 251,000,000
Income Tax Expense -212,000,000 66,000,000 2,082,000,000 20,000,000
Net Income -2,853,000,000 -265,000,000 -3,005,000,000 344,000,000
Per Share
EPS -3.30 -0.31 -3.48 0.40
EPS Diluted 0.00 0.00 0.00 0.00